Issue |
E3S Web Conf.
Volume 210, 2020
Innovative Technologies in Science and Education (ITSE-2020)
|
|
---|---|---|
Article Number | 06011 | |
Number of page(s) | 6 | |
Section | Livestock and Veterinary | |
DOI | https://doi.org/10.1051/e3sconf/202021006011 | |
Published online | 04 December 2020 |
Effectiveness of the new Iverlong prolonged-release drug for gastrointestinal nematodoses in sheep
1 Moscow Veterinary Academy named after K.I. Skriabin, 109472, Academician Skryabin str., 23, Moscow, Russia
2 Federal Scientific Center “All-Russian Institute of Experimental Veterinary Medicine”, 109428, Ryazansky prospect, 24, building 1, Moscow, Russia
3 North Caucasus Federal Agricultural Research Center, 355017, Stavropol, Zootehnicheskiy str., 15, Stavropol, Russia
* Corresponding author: mariamirabella1982@gmail.com
The article presents the results of experiment on testing a prolonged form of the Iverlong drug against gastrointestinal nematodes in sheep. The work was carried out on 30 lambs. The lambs of the first group were subcutaneously injected with the Iverlong preparation at a dose of 1 ml/50 kg of live weight (in 1 ml of 50 mg of Ivermectin plus PLGA prolongator), the lambs of the second group were treated with the same preparation, but at a dose of 0.5 ml/50 kg of live weight. The lambs of the third group served as a control, which were subcutaneously injected with the well-known Ivomek drug in the recommended dose (1 ml/50 kg of live weight). The effectiveness from the prolonged form of Iverlong in 2 doses against nematodes of the gastrointestinal tract was taken into account by means of coprological studies before drug administration and every 15 days for three months. According to the results of coprological studies, it was found that the Iverlong drug in a dose of 1ml/50 kg of the animal’s live weight showed a high prolonged anthelmintic effect and for 60 days protected animals from infection by nematodes of the gastrointestinal tract.
© The Authors, published by EDP Sciences, 2020
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.